tm
Seeing Is Believing
tm
Seeing Is Believing
GANX is currently covered by 5 analysts with an average price target of $7.27. This is a potential upside of $4.24 (139.93%) from yesterday's end of day stock price of $3.03.
Gain Therapeutics's activity chart (see below) currently has 5 price targets and 22 ratings on display. The stock rating distribution of GANX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 5% with an average time for these price targets to be met of 42.8 days.
Highest price target for GANX is $9, Lowest price target is $6, average price target is $7.27.
Most recent stock forecast was given by HARTAJ SINGH from OPPENHEIMER on 23-Apr-2024. First documented stock forecast 12-Apr-2021.
Currently out of the existing stock ratings of GANX, 17 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
9
$5.81 (182.13%)
10
6 days ago
0/4 (0%)
$5.61 (165.49%)
Buy
9
$5.81 (182.13%)
9
28 days ago
0/8 (0%)
$5.17 (134.99%)
Buy
6
$2.81 (88.09%)
6
1 months 2 days ago
0/4 (0%)
$2.27 (60.86%)
Buy
10
$6.81 (213.48%)
30
1 years 5 months 18 days ago
0/2 (0%)
$6.79 (211.53%)
Buy
5
$1.81 (56.74%)
11
1 years 8 months 10 days ago
1/4 (25%)
$1.34 (36.61%)
214
What is GANX (Gain Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on GANX (Gain Therapeutics) with a proven track record?
Which analyst has the current lower performing score on GANX (Gain Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GANX (Gain Therapeutics)?
Which analyst is the currently most bullish on GANX (Gain Therapeutics)?
Which analyst is the currently most reserved on GANX (Gain Therapeutics)?
